Archive for December 2017
Government recognition for Leeds City Region medtech expertise
Research into innovative medical technologies has been recognised in the Government’s Industrial Strategy Life Sciences Sector Deal.
Read MoreNew N8 Research Partnership director appointed
The N8 Research Partnership (N8), a collaboration of the North’s eight leading research universities, including Leeds, has announced the appointment of Dr Annette Bramley as its new director. N8 is the partnership body for the universities of Durham, Lancaster, Leeds, Liverpool, Manchester, Newcastle, Sheffield, and York and aims to maximise the impact of this research […]
Read MoreProof of Concept Fund launched by Arthritis Research UK
Arthritis Research UK, the biggest funder of research into the cause, treatment and cure of all forms of arthritis in the UK, and the Medical Technologies Innovation and Knowledge Centre, have joined together to offer proof of concept funding to progress research ideas with commercial potential.
Read MoreCreavo Medical Technologies secures U.S. FDA 510(k) approval for ground-breaking rule-out scanning device
Technology has the potential to revolutionise emergency department triage of chest pain patients
Read MoreSuccess of the IKC Proof of Concept Awards
A total of 26 applications have been reviewed for the Innovation and Knowledge Centre (IKC) Industry Partnered Proof of Concept (PoC) Awards in Regenerative Medical Devices and Medical Devices with Enhanced Regenerative Functions. The awards scheme, launched in September 2016, was open to all institutions eligible to Research Council funding, with the aim of accelerating […]
Read MoreScience and Innovation Audit published – Medical Technologies in the Leeds City Region
Government, industry and the NHS needs to invest between £200 million and £250 million in the Leeds City Region’s medical technology sector over the next five years, to enable it to exploit opportunities in the global health market – according to a new Science and Innovation audit.
Read MoreTissue Regenix acquires CellRight Technologies
CellRight Technologies, a US-based producer of regenerative osteoinductive bone scaffolds, has been acquired by Tissue Regenix Group plc (TRG). The deal was finalised on 9 August 2017. CellRight, brings a complementary regenerative technology to TRG which can be applied to allograft bone, following a process that removes DNA from tissue, so that malleable applications such […]
Read MoreGrowth in Vericel’s autologous cell therapy products reported
Vericel’s commercial product line consists of MACI (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adults; Carticel (expanded autologous chondrocytes for the repair of articular cartilage injuries in patients with inadequate responses to prior arthroscopic or other surgical procedures) and Epicel (sheets of a […]
Read MoreCreavo Medical Technologies closes £13.4m ($17m) funding round
Creavo Medical Technologies, a Medical Technologies IKC partner, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP Group plc, the developer of intellectual property-based businesses and working with […]
Read MoreDr Pierre-Alexis Mouthuy to give keynote address at IKC & Regener8 annual conference
Dr Pierre-Alexis Mouthuy will give the key note address at this years conference. The talk will be on ‘The translational journey of electrospun biomaterials designed to improve soft tissue repair.’ Dr Pierre-Alexis Mouthuy is a Senior Research Fellow at the Botnar Research Centre of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences in Oxford. Dr […]
Read More